Skip to main content

10-01-2021 | EASD 2021 | Conference coverage | News

Higher risk for incident CV, renal disease with type 1 vs type 2 diabetes

Author: Claire Barnard


medwireNews: People with type 1 diabetes have a greater risk for incident cardiovascular (CV) and renal disease than those with type 2 diabetes, suggest findings from a French nationwide observational study presented at the virtual 57th EASD Annual Meeting.

Denis Angoulvant and colleagues from the Centre Hospitalier Universitaire de Tours evaluated data from 50,623 adults with type 1 diabetes (average age 61.4 years) and 425,207 with type 2 diabetes (average age 68.6 years) who attended a French hospital in 2013 and were followed up for an average of 4.3 years.

Angoulvant reported that during 2,033,239 person–years of follow-up, the annual incidence rate in the total study population was 1.4% for myocardial infarction, 1.2% for ischemic stroke, 5.4% for heart failure, 3.4% for chronic kidney disease (CKD), 9.7% for all-cause mortality, and 2.4% for CV mortality.

When comparing age- and sex-adjusted event rates, the researchers found that people with type 1 diabetes aged over 60 years had a significant 1.2-fold higher risk for myocardial infarction than those with type 2 diabetes in the same age group.

The adjusted incidence of HF was also significantly elevated with type 1 versus type 2 diabetes for those aged 18–29 or over 60 years (1.1- to 1.4-fold increased risk), as was the risk for CKD in people aged 18–49 or over 60 years (1.1- to 2.4-fold increased risk).

The team also found that people in older age groups with type 1 diabetes had a significantly elevated mortality risk relative to those with type 2 diabetes. Specifically, the risk for all-cause mortality associated with type 1 versus type 2 diabetes was 1.1-fold higher for people aged over 60 years, while that for CV mortality was 1.1-fold higher for people aged 60–69 years.

In contrast to the other findings, the adjusted risk for ischemic stroke “did not markedly differ” among people with type 1 and type 2 diabetes, said Angoulvant.

He explained: “Although the prevalent burden of cardiovascular disease may be lower in patients with type 1 [versus] type 2 diabetes, those patients with type 1 diabetes may have a higher risk of incident myocardial infarction, heart failure, all-cause death, and cardiovascular death at middle-older ages.

“This observation highlights the need for improved prevention to reduce the burden of the surveillance.”

medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group

EASD Annual Meeting; Sept 27–Oct 1, 2021


Novel clinical evidence in continuous glucose monitoring

Novel clinical evidence in continuous glucose monitoring

How real-world studies complement randomized controlled trials

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.

This video has been developed through unrestricted educational funding from Abbott Diabetes Care.

Watch the video